Drawing for LIVEDROP

USPTO serial 79405565

LIVEDROP

Reviewed by CopyMark Law Group

Reg. 8081574Status 700Registered
Filing date
Status date
Registration date
Dec 30, 2025
Examiner
HAYS, CANDACE W
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LIVEDROP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John J. O'Malley

John J. O'Malley VOLPE KOENIG30 South 17th StreetSuite 1800Philadelphia, PA 19103

Goods and services

ClassDescriptionStatusFirst use
009Scientific research equipment with microfluidic functions for use in scientific analysis for growing, controlling, stimulating and monitoring in vitro cell and tissue culture; measuring equipment, apparatus and instruments for use in measuring temperature, electrical activity, pressure, flow rate, oxygen levels, pH rate in cell and tissue cultures; scientific research and laboratory apparatus, namely, droplet generator, microfluidic cell analyzer and cell sorter, flow cytometer, plate reader, cell counter, in the field of chemistry, educational apparatus and simulators; research laboratory analyzers for measuring, testing and analyzing blood and other body fluids; analysis equipment for research laboratories for measuring, testing and examining tissue, cells as well as biomolecules such as DNA, RNA and proteins; scientific research and laboratory analysis equipment for performing and evaluating histology, cytology, immune histology, immune histochemistry, in situ hybridization, PCR (polymerase chain reaction), NGS (next-generation sequencing), microarray hybridization (genetic chip hybridization or bio chip), flow cytometry and isolation of biomolecules such as DNA, RNA and proteins; all of the foregoing goods not in connection with data transfer; all of the foregoing devices, apparatus and instruments intended for scientific research laboratories in the medical, pharmaceutical and veterinary fieldsACTIVE—
010Medical diagnostic devices, apparatus and instruments for collecting and analyzing biological samples; cell culture instruments for medical use, namely, microfluidic droplet generator, microfluidic cell analyzer and cell sorter, flow cytometer, plate reader, cell counter, microfluidic chips; medical apparatus and instruments for monitoring blood properties; instruments for medical use, namely, microfluidic cell analyzer and cell sorter, flow cytometer, plate reader, cell counter; analysis apparatus for medical use, namely, cell analyzer, cytometer, flow cytometer, plate reader, microscope; automatic analyzers for medical diagnosis, namely, cell analyzer, flow cytometer, cell counter, PCR instruments; genetic testing apparatus for medical useACTIVE—
042Product research, design and development in relation to devices, computer software and materials with microfluidic functions intended for scientific research laboratories in the medical, pharmaceutical, chemical and veterinary fields; product research, design, and development in relation to cellular and tissue models intended for scientific research laboratories in the medical, pharmaceutical, chemical and veterinary fields; scientific research relating to all the aforementioned services; technical consulting services relating to all the aforementioned services; scientific information services relating to all the aforementioned services; research and development in the field of antibodies; research and development in the field of microorganisms and cells; scientific services, namely, cell analysis, cell repertoire screening, identification and selection of rare cells, gene library screening, eukaryotic et prokaryotic cell culture, single-cell functional screening, with respect to the isolation and cultivation of human cells and tissues; scientific, fundamental, translational, applied research in the field of pharmaceutical products; design and development of diagnostic apparatus; design of diagnostic apparatus and equipment; design and development of medical diagnostic apparatus; research and development in the field of diagnostic preparations; all of the foregoing services not in connection with data transferACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 23, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 7, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 7, 2026FIMPFINAL DISPOSITION PROCESSED—
Mar 30, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 19, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 2, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 2, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 30, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 30, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 11, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 11, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 5, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 14, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 16, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 15, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 15, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 14, 2024RFNTREFUSAL PROCESSED BY IB—
Nov 22, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 22, 2024RFRRREFUSAL PROCESSED BY MPU—
Nov 16, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 15, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2024DOCKASSIGNED TO EXAMINER—
Oct 16, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 16, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 3, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance